Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan
Abstract Background Heterocyclic aromatic amines (HAAs) may confer prostate cancer risk; however, the evidence is inconclusive and the activity of HAA-metabolizing enzymes is modulated by gene variants. The purpose of our study was to determine whether there was evidence of an association between HA...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Komiyama Printing Co. Ltd
2017-10-01
|
Series: | Environmental Health and Preventive Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12199-017-0681-0 |